Cite
Study of ER, PR, HER2/neu, p53, and Ki67 expression in primary breast carcinomas and synchronous metastatic axillary lymph nodes.
MLA
Khande, Tejal, et al. “Study of ER, PR, HER2/Neu, P53, and Ki67 Expression in Primary Breast Carcinomas and Synchronous Metastatic Axillary Lymph Nodes.” Indian Journal of Cancer, vol. 57, no. 2, Apr. 2020, pp. 190–97. EBSCOhost, https://doi.org/10.4103/ijc.IJC_610_18.
APA
Khande, T., Joshi, A., Khandeparkar, S., Kulkarni, M., Gogate, B., Kakade, A., Sahu, P., Khillare, C., Khande, T. A., Joshi, A. R., Khandeparkar, S. G. S., Kulkarni, M. M., Gogate, B. P., Kakade, A. R., Sahu, P. D., & Khillare, C. D. (2020). Study of ER, PR, HER2/neu, p53, and Ki67 expression in primary breast carcinomas and synchronous metastatic axillary lymph nodes. Indian Journal of Cancer, 57(2), 190–197. https://doi.org/10.4103/ijc.IJC_610_18
Chicago
Khande, Tejal, Avinash Joshi, Siddhi Khandeparkar, Maithili Kulkarni, Bageshri Gogate, Aniket Kakade, Piyush Sahu, et al. 2020. “Study of ER, PR, HER2/Neu, P53, and Ki67 Expression in Primary Breast Carcinomas and Synchronous Metastatic Axillary Lymph Nodes.” Indian Journal of Cancer 57 (2): 190–97. doi:10.4103/ijc.IJC_610_18.